[go: up one dir, main page]

MA45048A - Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one - Google Patents

Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one

Info

Publication number
MA45048A
MA45048A MA045048A MA45048A MA45048A MA 45048 A MA45048 A MA 45048A MA 045048 A MA045048 A MA 045048A MA 45048 A MA45048 A MA 45048A MA 45048 A MA45048 A MA 45048A
Authority
MA
Morocco
Prior art keywords
pyrrolo
pyrimidin
new derivative
derivative
new
Prior art date
Application number
MA045048A
Other languages
English (en)
Inventor
Naoki EGASHIRA
Koji Ichikawa
Yu KOBAYAKAWA
Takumitsu Machida
Toshihiro Sakamoto
Tetsuya Sugimoto
Fuyuki Yamamoto
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA45048A publication Critical patent/MA45048A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA045048A 2016-05-20 2017-05-19 Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one MA45048A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016101599 2016-05-20

Publications (1)

Publication Number Publication Date
MA45048A true MA45048A (fr) 2019-03-27

Family

ID=60325930

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045048A MA45048A (fr) 2016-05-20 2017-05-19 Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one

Country Status (21)

Country Link
US (1) US10538528B2 (fr)
EP (1) EP3459953B1 (fr)
JP (1) JP6576553B2 (fr)
KR (1) KR102149734B1 (fr)
CN (1) CN109153681B (fr)
AU (1) AU2017265769B9 (fr)
BR (1) BR112018073721B1 (fr)
CA (1) CA3024831C (fr)
DK (1) DK3459953T3 (fr)
ES (1) ES2882018T3 (fr)
HU (1) HUE055846T2 (fr)
MA (1) MA45048A (fr)
MX (1) MX374576B (fr)
MY (1) MY185962A (fr)
PH (1) PH12018502411A1 (fr)
PL (1) PL3459953T3 (fr)
PT (1) PT3459953T (fr)
RU (1) RU2713181C1 (fr)
SG (1) SG11201810360YA (fr)
TW (2) TWI732187B (fr)
WO (1) WO2017200087A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023063432A1 (fr) * 2021-10-13 2023-04-20 Taiho Pharmaceutical Co., Ltd. Méthodes de traitement pour des sujets atteints d'un cancer ayant une voie mapk et/ou pi3k dérégulée
WO2023143424A1 (fr) * 2022-01-27 2023-08-03 四川海思科制药有限公司 Dérivé azacyclique et son application médicale
JPWO2024009977A1 (fr) * 2022-07-05 2024-01-11
CN115850244B (zh) * 2023-02-24 2023-05-16 成都大学 一种托吡司他的制备方法
WO2025260014A1 (fr) * 2024-06-14 2025-12-18 Tenvie Therapeutics, Inc. Composés, compositions et procédés

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005249380C1 (en) * 2004-04-23 2012-09-20 Exelixis, Inc. Kinase modulators and methods of use
GB0608184D0 (en) * 2006-04-25 2006-06-07 Astex Therapeutics Ltd Pharmaceutical compounds
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
RU2517804C2 (ru) * 2008-08-08 2014-05-27 Нестек С.А. Машина для приготовления напитков с ручкой для переноски, имеющая адаптируемый внешний вид и содержащая сменные боковые панели
AR074072A1 (es) * 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
MX2012004780A (es) * 2009-10-23 2012-08-23 Lilly Co Eli Inhibidores de akt.
WO2014143612A1 (fr) * 2013-03-11 2014-09-18 Merck Patent Gmbh Dérivés de 6-[4-(1 h-imidazol-2-yl)pipéridin-1 -yl]pyrimidin-4-amine en tant que modulateurs de l'activité kinase
JP6398659B2 (ja) 2014-11-28 2018-10-03 アイシン・エィ・ダブリュ株式会社 歯形部品の製造方法および歯形部品製造装置

Also Published As

Publication number Publication date
EP3459953A4 (fr) 2020-01-08
CN109153681A (zh) 2019-01-04
MX2018014022A (es) 2019-04-04
PL3459953T3 (pl) 2021-11-22
MX374576B (es) 2025-03-06
EP3459953A1 (fr) 2019-03-27
US20190292190A1 (en) 2019-09-26
TWI679202B (zh) 2019-12-11
CA3024831C (fr) 2021-06-08
TW201920187A (zh) 2019-06-01
ES2882018T3 (es) 2021-11-30
EP3459953B1 (fr) 2021-06-30
CN109153681B (zh) 2021-06-04
AU2017265769A1 (en) 2018-11-29
PT3459953T (pt) 2021-07-29
AU2017265769B9 (en) 2019-05-30
JPWO2017200087A1 (ja) 2018-12-27
JP6576553B2 (ja) 2019-09-18
WO2017200087A1 (fr) 2017-11-23
US10538528B2 (en) 2020-01-21
CA3024831A1 (fr) 2017-11-23
TW201742867A (zh) 2017-12-16
HUE055846T2 (hu) 2021-12-28
BR112018073721B1 (pt) 2023-12-05
DK3459953T3 (da) 2021-08-23
BR112018073721A2 (pt) 2019-02-26
MY185962A (en) 2021-06-14
RU2713181C1 (ru) 2020-02-04
PH12018502411A1 (en) 2019-09-16
KR102149734B1 (ko) 2020-08-31
HK1259613A1 (zh) 2019-12-06
KR20180120777A (ko) 2018-11-06
TWI732187B (zh) 2021-07-01
SG11201810360YA (en) 2018-12-28
AU2017265769B2 (en) 2019-05-02

Similar Documents

Publication Publication Date Title
DK3478682T3 (da) [1,2,4]triazolo[1,5-a]pyridinylsubstituerede indolforbindelser
ZA201905456B (en) Pyrrolo[1,2-b]pyridazine derivatives
HUE051424T2 (hu) RET kináz inhibitor szubsztituált pirazolo[1,5-a]piridin vegyületek
ZA201802743B (en) Novel pyrazolo pyrimidine derivatives
LT3429591T (lt) Pakeistojo tieno[2,3-d]pirimidino dariniai kaip menino-mll inhibitoriai ir jų panaudojimo būdai
LT3555097T (lt) Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai
LT2968294T (lt) 7-benzil-10-(2-metilbenzil)-2,6,7,8,9,10-heksahidroimidazo[1,2-a]pirido[4,3-d]pirimidin-5(3h)-onas, skirtas vėžio gydymui
IL248109B (en) Deuterium history of -1(4-fluorophenyl-4-[(6br,10as)-2,3,6b,9,10,10a-hexahydro-3-methyl-h1-pyrido[3′,4′:4,5 [Pyrrolo[3,2,1-de]quinoxaline-8(h7)-yl-1-butanone
IL243092A0 (en) New triazolo[d–4,5]pyrimidine histories
LT3805222T (lt) 7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-heksahidroimidazo[1,2-a]pirido[3,4-e]pirimidino-5(1h)-ono dariniai, jų druskos ir jų naudojimas terapijai
IL259004B (en) [4,2,1]triazolo[5,1-a]pyrimidin-7-yl compound
EP3452481A4 (fr) Imidazo[1,2-b]pyridazines substituées, imidazo[1,5-b]pyridazines substituées, composés apparentés et leur utilisation dans le traitement de troubles médicaux
IL291597A (en) Selective sulfonation of benzodiazepine derivatives
DK3177627T3 (da) Imidazo[1,2-a]-pyrazolo[4,3-e]-pyrimidin-4-on-derivater med pde1-hæmmende aktivitet
MA45048A (fr) Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one
IL247948B (en) 7,6,5,4-tetrahydro-pyrazolo[5,1-a]pyrimidine derivatives and 3,2-dihydro-h1-imidazo[2,1-b]pyrazole derivatives as ros1 inhibitors
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
IL258070A (en) Cyclic ether history of pyrazolo[5,1-a]pyrimidine-3-carboxamide
EP3190111A4 (fr) Dérivés de pyrazolo[3,4-c]pyridine
GB201522532D0 (en) Novel pyrrolo[3,2-c]pyridine-6-amino derivatives
PL3597648T3 (pl) METODA WYTWARZANIA 3,6-DIPODSTAWIONEJ POCHODNEJ IMIDAZO[1, 2-b]PIRYDAZYNY
ZA201902828B (en) Crystal of pyrido[3, 4-d]pyrimidine derivative or solvate thereof
EP3640253A4 (fr) Dérivé de 6h-thiéno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazépine
IL267305A (en) Process for the manufacture of diazepine derivatives
TH1601001194A (th) อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่